跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMATINIB QILU 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IMATINIB QILU 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
IMATINIB QILU 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 25, 2021
Approval ID
4fd0ae363dc511a5
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
4fd0ae363dc511a5
Drug Cima Aemps Name
IMATINIB QILU 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85051
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Sun Pharma Laboratorios S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2021-01-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
IMATINIB MESILATO
119,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 25, 2021
Approval ID
4fd0ae363dc511a5
Type
Standard
Back to CIMA-AEMPS Approvals